Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

C. Boutros, Ahmad A. Tarhini, Émilie Routier, Olivier Lambotte, François Le Roy Ladurie, Franck Carbonnel, Hassane Izzeddine, Aurélien Marabelle, Stéphane Champiat, Armandine Berdelou, Émilie Lanoy, Matthieu Texier, Cristina Libenciuc, Alexander M.M. Eggermont, Jean‐Charles Soria, Christine Mateus, Caroline Robert

View at source ↗Review1,101 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/nrclinonc.2016.58
Published
May 4, 2016
Venue
Nature Reviews Clinical Oncology
DOI
10.1038/nrclinonc.2016.58
PubMed
27141885
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics